Guido Brink

Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial

Laurent Jacob, Anke Witteveen, Inès Beumer, 2020, Communications Biology.

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

Wim H van Harten, Valesca P Retel, Guido Brink, 2007, The Lancet. Oncology.